v3.26.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2025
Mar. 17, 2026
Jun. 30, 2025
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Entity Transition Report false    
Entity File Number 001-40445    
Entity Registrant Name CENTESSA PHARMACEUTICALS PLC    
Entity Incorporation, State or Country Code X0    
Entity Tax Identification Number 98-1612294    
Entity Address, Address Line One 3rd Floor    
Entity Address, Address Line Two 1 Ashley Road    
Entity Address, Address Line Three Altrincham    
Entity Address, City or Town Cheshire    
Entity Address, Country GB    
Entity Address, Postal Zip Code WA14 2DT    
Country Region +1    
City Area Code 617)    
Local Phone Number 468-5770    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 1,227,567,000
Entity Common Stock, Shares Outstanding   154,568,531  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the Registrant’s definitive proxy statement for the annual meeting of stockholders or an amendment to this Annual Report on Form 10-K which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2025.
   
Entity Central Index Key 0001847903    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
Ordinary shares      
Document Information [Line Items]      
Title of 12(b) Security Ordinary shares, nominal value £0.002 per share    
Trading Symbol CNTA    
Security Exchange Name NASDAQ    
American Depositary Shares      
Document Information [Line Items]      
Title of 12(b) Security American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share    
Trading Symbol CNTA    
Security Exchange Name NASDAQ